Ciprofloxacin | ||||
PIRRT (present study) | EDD | IHD [49] | ||
QEffluent (mL/min) | 83.3 | 17–50b | N/S | 500 |
CLRRT (mL/min) | 55.0 ± 13.3a | 13.3–41.7b | N/S | 57.2 |
CLOFF-RRT (mL/min) | 108.3 ± 48.3a | 102–166b | N/S | N/R |
t½ ON-RRT (h) | 8.2 ± 5.0a | 9.4–13.8b | N/S | 3.2 ± 0.4a |
t½ OFF-RRT (h) | 13.9 ± 10.5a | N/A | N/S | 5.8 ± 0.9a |
Levofloxacin | ||||
PIRRT (present study) | EDD [27] | IHD [50] | ||
QEffluent (mL/min) | 83.3 | 17–50b | 160 | 600 |
CLRRT (mL/min) | 48.3 + 15.0a | 11.0–27.6b | 48.8 [25.2–72.5]c | 84.4 [61.8–107.6]c |
CLOFF-RRT (mL/min) | 24.7 + 11.7a | 15.0–30.9b | 51.0 [49.0–52.8]c | 37.0 [12.8–42.7]c |
t½ ON-RRT (h) | 16.7 + 6.0a | 8.3–45.9b | 10.3 [10.0–10.6]c | N/R |
t½ OFF-RRT (h) | 52.8 + 17.0a | N/A | 34.5 [21.2–47.7]c | 34.4 [28.4–39.3]c |